Form 6-K Medigus Ltd. For: Feb 07

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2023

 

Commission File Number 001-37381

 

MEDIGUS LTD.
(Translation of registrant’s name into English)

 

10 HaNechoshet Street, 6971072, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒  Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   ☐

 

 

EXPLANATORY NOTE

 

On February 7, 2023, Medigus Ltd. issued a press release titled: “Medigus: Charging Robotics was Nominated for and Submitted its AI based Solution to the 14th Innovation World Cup.” A copy of this press release is furnished herewith as Exhibit 99.1.

 

 

EXHIBIT INDEX

 

Exhibit		Description
99.1		Press release dated February 7, 2023

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	MEDIGUS LTD.
Date: February 7, 2023	By:	/s/ Dinar Tali
		Dinar Tali
		Financial Officer Chief

 

 

3

 

ATTACHMENTS / EXHIBITS

PRESS RELEASE DATED FEBRUARY 7, 2023

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Helo Corp Announces Annual 2023 Results
• Net Income of R$ 55.3 mm in 1Q24, a 90.1% Increase YOY and Leases EBITDA Margin of 72.1%
• ROSEN, A RANKED AND LEADING FIRM, Encourages Innoviz Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INVZ, INVZW